Skip to main content
Clinical Trials/JPRN-jRCT1011220023
JPRN-jRCT1011220023
Recruiting
N/A

A prospective observational study to investigate real-world IMmunogenicity of theraPeutic Antibodies and to identify faCTors responsible for the interindividual variability - IMPACT study

Fukudo Masahide0 sites300 target enrollmentOctober 29, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Fukudo Masahide
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 29, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fukudo Masahide

Eligibility Criteria

Inclusion Criteria

  • Subjects whose medical care and prognostic information can be obtained from medical records

Exclusion Criteria

  • Subjects presenting with any of the following will be excluded from the study:
  • 1\. Subjects who requested non\-participation in this study based on a published opt\-out document.
  • 2\. Subjects who are participating in or interested in participating in other clinical trials during the study period.
  • 3\. Subjects who are judged as not suitable for participating in this study by treating physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials